Physician profile
James Choi
NPI 1255321519
$716.09
in general payments reported to CMS, 2019-2025
11 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $13.73 · 2023: $53.78 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $163.61 | 2019-2020 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $122.32 | 2025 | |
| Neotract INC. | $100.44 | 2019 | |
| Cook Medical LLC | $64.72 | 2025 | Zenith Spiral-Z |
| Endo Pharmaceuticals INC. | $32.43 | 2023 | Xiaflex |
| Janssen Biotech, INC. | $22.77 | 2025 | Rybrevant, Carvykti |
| Janssen Pharmaceuticals, INC | $21.35 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $18.89 | 2025 | Keytruda |
| Endo USA, INC. | $18.39 | 2025 | Xiaflex |
| Boston Scientific Corporation | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.